HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry
Co-Author, Cannabis Industry Journal, Sept. 13, 2023
In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary Xavier Becerra shared his agency’s recommendation that, based on data and scientific analysis, cannabis, a Schedule I drug under the Controlled Substances Act, should be reclassified as a Schedule III drug. The announcement was made on Wednesday, August 30.
HHS’ conclusion was sent by letter to the Drug Enforcement Administration (DEA), the agency with authority to reclassify how various substances are treated under federal drug laws. The HHS recommendation means that the nation’s top health agency no longer considers cannabis a drug that lacks medical value and carries the high potential for abuse.
Click here to read the full article.
Contributors:
Recent Insights
Read MoreCalifornia’s AB 1050: Removing Barriers to Housing Redevelopment on Commercial Properties
Presentation | December 05, 2025International Considerations in Your Life Sciences IP Due Diligence Review
Presentation | December 05, 2025Vested Rights and Development Agreements
Client Alert | December 04, 2025Risk Assessments Under the New CCPA Regulations Commence Jan. 1, 2026
Article | December 04, 2025Legislative Updates for Planning and Zoning
Client Alert | December 04, 2025Amazon v. Malloy: A Shakeup in NV Wage and Hour Law Results in New Legislation
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.